Medpage Today on MSN1mon
FDA Approves New Option for RosaceaThe FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in ...
U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback